These drugs work by removing amyloid plaques—unusual clumps of proteins that build up in the brain and block cell communication. Leqembi and Kisunla represent a great step forward in Alzheimer’s ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...